Discussing the basic molecular mechanisms of neurodegenerative disorders and continuing the detailed exploration of zebrafish physiology, genetics, technologies including CRISPR/Cas9 genome editing, and analysis of zebrafish models highlighting their strengths in modelling disease progression and therapeutic testing.